×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
H. Lundbeck A/S' (CPH:HLUN B) largest shareholders are private equity firms with 69% ownership, individual investors own 22%
Simply Wall Street
Key Insights The considerable ownership by private equity firms in H. Lundbeck indicates that they collectively have a...
4 days ago
Epilepsy Drugs Market Report and Global Forecast 2024-2030, Featuring Eisai, UCB, H. Lundbeck, GW ...
Yahoo Finance
Global Epilepsy Drugs Market Global Epilepsy Drugs Market Dublin, May 06, 2024 (GLOBE NEWSWIRE) -- The "Epilepsy Drugs Market, Size,...
1 week ago
Lundbeck initiates Lu AG09222 migraine prevention trial
Clinical Trials Arena
Biopharmaceutical company H. Lundbeck has initiated the PROCEED Phase IIb study to evaluate the efficacy and safety of Lu AG09222,...
1 month ago
Lundbeck number of employees 2009-2023
Statista
The average number of employees of Danish pharmaceutical company H. Lundbeck fluctuated during the period from 2009 to 2023.
2 months ago
Rexulti the surprise winner in April's TV drug ad spending list
Fierce Pharma
Otsuka and Lundbeck's atypical antipsychotic Rexulti has taken the crown away from AbbVie as the largest TV drug ad spender in April.
6 days ago
USPTO Slams Lundbeck's PTSD Drug Patent Term Suit
Law360
The U.S. Patent and Trademark Office is going for an early win in Virginia federal court where Danish drugmaker H. Lundbeck A/S is seeking...
3 months ago
Skinny Label Avoids Infringement
Patently-O
by Dennis Crouch. H. Lundbeck A/S v. Lupin Ltd., Nos. 2022-1194, 2022-1208, 2022-1246 (Fed. Cir. Dec. 7, 2023) (Opinion by Judge Dyk,...
5 months ago
Otsuka and Lundbeck's schizophrenia treatment gains EC approval
Pharmaceutical Technology
The European Commission (EC) has approved Otsuka Pharmaceutical Europe and H Lundbeck's Abilify Maintena 720mg/960mg (aripiprazole) for the...
1 month ago
Lundbeck Earnings: Demand for Strategic Brands Helps Offset Generic Erosion of Mature Portfolio
Morningstar
Lundbeck HLUN B reported second-quarter results highlighted by revenue of DKK 4.9 billion, representing a 10% increase from the prior-year...
8 months ago
Lundbeck Sues USPTO to Force PTSD-Drug Patent Term Extension (1)
Bloomberg Law News
H. Lundbeck A/S sued the US Patent and Trademark Office seeking a federal court's judgment forcing the agency to extend the life of a patent...
8 months ago